2026 Cannabis Psychiatric Tradeoffs in Pain and Policy
This digest covers 2026 cannabis psychiatric tradeoffs with a focus on pain management and policy developments. It synthesizes recent articles to provide clinical context. Dr. Caplan offers insights on balancing therapeutic benefits and psychiatric risks.
Cannabis Medicine Maturation: Pain and Psychiatric Tradeoffs
Cannabis medicine maturation is reshaping pain management and psychiatric care. This digest reviews recent evidence on cannabis as an opioid alternative and its psychiatric tradeoffs. Clinicians must balance benefits and risks with precision in this…
UNO Draw 25
Or you could talk to a cannabis doctor / Further Reading Cannabis NewsRecreational drugs triple the risk of stroke in young people, study finds | The IndependentEvidence WatchDaily Digest 2026-03-08CED Clinic BlogCannabis-Infused Beverages as Alcohol…
Cannabinoid Beverage Substitution: What New York’s Data Reveals
Recent clinical research on cannabinoid beverage substitution reveals measurable changes in alcohol consumption patterns. Adults choosing cannabinoid beverages over alcohol may experience different health outcomes. This emerging data informs…
Link Between Cannabis and Anxiety, Depression Strengthens Over Time
Recent studies reveal a strengthening cannabis anxiety link that challenges previous perceptions of cannabis as a benign anxiolytic. This evolving evidence suggests cannabis may exacerbate mood disorders like anxiety and depression. Clinicians should…
New York Cannabis, Five Years In: Markets, Medicine, and the Messy Middle
The New York cannabis medical program faces challenges after five years of legalization, with market fragmentation impacting clinical care. Clinicians must navigate inconsistent product quality and regulatory gaps. Understanding the new york cannabis…
Cannabis Hyperemesis Syndrome: Clinical Signs to Watch
Cannabis hyperemesis syndrome clinical signs are critical for early diagnosis. This syndrome causes severe nausea, vomiting, and abdominal pain in chronic cannabis users. Recognizing these clinical signs helps reduce unnecessary tests and improves…
Cannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years
A 2026 study highlights cannabis beverage substitution alcohol as a potential alternative to traditional drinking. Adults substituting THC or CBD beverages showed measurable differences in consumption behavior. This research informs harm reduction and…
New Research on Cannabis Beverages vs Alcohol
Cannabis beverages alcohol substitution research highlights emerging evidence on THC and CBD drinks as alternatives to alcohol. This research suggests potential harm reduction benefits. Clinicians should consider these findings cautiously while awaiting…
Limits of THC Blood Testing in Cannabis Clinical Updates 2026
This digest highlights the limits of THC blood testing in clinical and forensic settings, emphasizing its inadequacy for impairment assessment. It also covers cannabinoid hyperemesis syndrome and prenatal cannabis exposure risks. These topics are…
